Assessment of Monocyte/HDL Ratio in Branch Retinal Vein Occlusion

References

• Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1094–1101. doi:10.1016/j.ophtha.2010.01.058.
   PubMed Web of Science ®Google Scholar
• Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313–319. doi:10.1016/j.ophtha.2009.07.017.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc. 2000;98:133–141.
   PubMedGoogle Scholar
• Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The blue mountains eye study. Arch Ophthalmol. 1996;114(10):1243–1247. doi:10.1001/archopht.1996.01100140443012.
   PubMed Web of Science ®Google Scholar
• Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013;33(5):901–910. doi:10.1097/IAE.0b013e318271f265.
   PubMed Web of Science ®Google Scholar
• Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH. Virchow’s contribution to the understanding of thrombosis and cellular biology. Clin Med Res. 2010;8(3–4):168–172. doi:10.3121/cmr.2009.866.
   PubMedGoogle Scholar
• Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131:61–77.
   PubMed Web of Science ®Google Scholar
• Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb. 2002;32:308–311. doi:10.1159/000073587.
   PubMed Web of Science ®Google Scholar
• Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;5:692–699.
   Google Scholar
• Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol. 2001;88:3J–6J.
   PubMed Web of Science ®Google Scholar
• Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678. doi:10.1161/hc4601.099485.
   PubMed Web of Science ®Google Scholar
• Ancuta P, Jianbin W, Gabuzda D. CD16+ monocytes produce IL-6, CCL2 and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156–1164. doi:10.1189/jlb.0206125.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37:710–718. doi:10.1111/j.1440-1681.2009.05338.x.
   PubMed Web of Science ®Google Scholar
• Mirza E, Oltulu R, Katipoğlu Z, Mirza GD, Özkağnıcı A. Monocyte/HDL ratio and lymphocyte/monocyte ratio in patients with pseudoexfoliation syndrome. Ocul Immunol Inflamm. 2018;1–5. Available from: doi:10.1080/09273948.2018.1545913.
   PubMed Web of Science ®Google Scholar
• Kormaz A, Demir M, Unal S, et al. Monocyte-to-high density lipoprotein ratio (MHR) can predict the significance of angiographically intermediate coronary lesions. Int J Cardiovas Acad. 2017;3:16–20. doi:10.1016/j.ijcac.2017.05.008.
   Google Scholar
• Bolayir A, Gokce SF, Çiğdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52(2):150–155. doi:10.1016/j.pjnns.2017.08.011.
   PubMed Web of Science ®Google Scholar
• Sodi A, Giambene B, Marcucci R, et al. Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion. Retina. 2011;31:724–729. doi:10.1097/IAE.0b013e3181eef419.
   PubMed Web of Science ®Google Scholar
• O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126:692–699. doi:10.1001/archopht.126.5.692.
   PubMed Web of Science ®Google Scholar
• Bertelsen M, Linneberg A, Rosenberg T, et al. Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ. 2012;345:e7885. doi:10.1136/bmj.e7885.
   PubMed Web of Science ®Google Scholar
• Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009;23(5):225–229. doi:10.1016/j.blre.2009.07.002.
   PubMed Web of Science ®Google Scholar
• Chen YY, Sheu SJ, Hu HY, Chu D, Chou P. Association between retinal vein occlusion and an increased risk of acute myocardial infarction: a nationwide population-based follow-up study. Plos One. 2017;12(9):e0184016. doi:10.1371/journal.pone.0184016.
   PubMed Web of Science ®Google Scholar
• Rim TH, Han JS, Oh J, Kim DW, Kang SM, Chung EJ. Retinal vein occlusion and the risk of acute myocardial infarction development: a 12-year nationwide cohort study. Sci Rep. 2016;6:22351. doi:10.1038/srep22351.
   PubMed Web of Science ®Google Scholar
• Rim TH, Oh J, Lee CS, Lee SC, Kang SM, Kim SS. Evaluation of the association between retinal vein occlusion and the risk of atrial fibrillation development: a 12-year, retrospective nationwide cohort study. Sci Rep. 2016;6:34708. doi:10.1038/srep34708.
   PubMed Web of Science ®Google Scholar
• Bertelsen M, Linneberg A, Christoffersen N, Vorum H, Gade E, Larsen M. Mortality in patients with central retinal vein occlusion. Ophthalmology. 2014;121:637–642. doi:10.1016/j.ophtha.2013.07.025.
   PubMed Web of Science ®Google Scholar
• Th R, Dw K, Js H, Ej C. Retinal vein occlusion and the risk of stroke development: a 9-year nationwide population-based study. Ophthalmology. 2015;122(6):1187–1194. doi:10.1016/j.ophtha.2015.01.020.
   PubMed Web of Science ®Google Scholar
• Sönmez O, Ertaş G, Bacaksız A, et al. Relation of neutrophil to lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anadolu Kardiyol Derg. 2013;13:662–667. doi:10.5152/akd.2013.188.
   PubMed Web of Science ®Google Scholar
• Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105(2):186–191. doi:10.1016/j.amjcard.2009.09.007.
   PubMed Web of Science ®Google Scholar
• Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15:942–947. doi:10.1089/dia.2013.0097.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34:69–74. doi:10.1159/000341583.
   PubMed Web of Science ®Google Scholar
• Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol. 2015;25(4):343–346. doi:10.5301/ejo.5000570.
   PubMed Web of Science ®Google Scholar
• Ucar FM. A potential marker of bare metal stent restenosis: monocyte count-to-HDL cholesterol ratio. BMC Cardiovasc Disord. 2016;16:186. doi:10.1186/s12872-016-0371-7.
   PubMed Web of Science ®Google Scholar
• Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22(5):476–482. doi:10.1177/1076029615594002.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619–1625. doi:10.1007/s11255-014-0730-1.
   PubMed Web of Science ®Google Scholar
• Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–1086. doi:10.1016/j.hlc.2016.02.023.
   PubMed Web of Science ®Google Scholar
• Dogan A, Oylumlu M. Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X. Acta Cardiol. 2017;72(5):516–521. doi:10.1080/00015385.2017.1299521.
   PubMed Web of Science ®Google Scholar
• Açıkgöz SK, Açıkgöz E, Şensoy B, Topal S, Aydoğdu S. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23:505–512.
   PubMed Web of Science ®Google Scholar
• Aydin E, Ates I, Arikan MF, Yilmaz N, Dede F. The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension. Hypertens Res. 2017;40:758–764. doi:10.1038/hr.2017.36.
   PubMed Web of Science ®Google Scholar